New Delhi: The University of Leeds (UoL) has invited applications for its MSc in Molecular Medicine programme for the September 2026 intake, offering students advanced training in cancer biology, disease mechanisms and modern therapeutic research.
The 12-month full-time programme is designed for science graduates and clinicians seeking careers in academic research, clinical services, biotechnology and healthcare industries. The course focuses on molecular approaches to diagnosing, preventing and treating cancer, chronic, autoimmune and genetic diseases.
According to the university, students will receive specialised training in molecular biology, immunology, cell biology and chemistry, while also undertaking independent research projects within leading biomedical institutes. The programme offers two specialist pathways — Disease Mechanisms and Treatments, and Cancer Biology and Therapy.
The university said the course aims to equip students with scientific and analytical skills needed to evaluate modern cancer research challenges and contribute to the development of new therapies and clinical applications.
Applicants must possess a first-class or equivalent undergraduate degree in a relevant subject from a recognised Indian university. The application deadline is July 31, 2026, while classes will commence in September 2026.
The total tuition fee for the programme is £32,000 (approximately ₹37.67 lakh). Indian students will be eligible for scholarships, including the £6,000 International Masters Regional Scholarship and the International Excellence Scholarship offering up to 50 per cent fee reduction.
Students enrolled in the programme will also gain exposure through the university’s Global Industry Programme, a two-week virtual consultancy initiative aimed at providing industry experience and professional networking opportunities.
Graduates from the programme have reportedly progressed to PhD research, healthcare services and research roles in organisations such as Nikon, Cyprotex, Lonza and the UK’s National Health Service (NHS).
